Nature Communications · 2021 · 130 citations · 49 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsGenomicsMolecular OncologyCancer GenomicsClinical GenomicsGenome SequencingGenomic ProfilingHematopoietic NeoplasmsMultiple MyelomaApobec EnzymesApobec Mutation SignaturesInitiationMyeloma PathogenesisWhole-genome Sequence AnalysisWhole-genome Sequencing Analysis
Multiple myeloma (MM) is consistently preceded by precursor conditions recognized clinically as monoclonal gammopathy of undetermined significance (MGUS) or smoldering myeloma (SMM). We interrogate the whole genome sequence (WGS) profile of 18 MGUS and compare them with those from 14 SMMs and 80 MMs. We show that cases with a non-progressing, clinically stable myeloma precursor condition (n = 15) are characterized by later initiation in the patient's life and by the absence of myeloma defining genomic events including: chromothripsis, templated insertions, mutations in driver genes, aneuploidy, and canonical APOBEC mutational activity. This data provides evidence that WGS can be used to recognize two biologically and clinically distinct myeloma precursor entities that are either progressive or stable.
49
The repertoire of mutational signatures in human cancer
Mi Ni Huang, Alvin Wei Tian Ng, Arnoud Boot et al. · Nature · 2020 · 3.7K citations · Full text
Life Sciences, Genetics, Oncology +14
Universal Patterns of Selection in Cancer and Somatic Tissues
Iñigo Martincorena, Keiran Raine, Moritz Gerstung et al. · Cell · 2017 · 1.7K citations · Full text
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman, Michael S. Lawrence, Jonathan J. Keats et al. · Nature · 2011 · 1.4K citations · Full text
Life Sciences, Genetics, Oncology +15